NCT07177885View on ClinicalTrials.gov

Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans

Not yet recruitingOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2028

Conditions
Migraine
Interventions
BIOLOGICAL

Blood collection

Blood sampling. For patients who have had their cerebrospinal fluid sample taken as part of their treatment, a surplus sample will be used to perform the same measurements.

Trial Locations (1)

Unknown

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

University of the Basque Country (UPV/EHU)

OTHER

collaborator

Lariboisière Hospital

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT07177885 - Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans | Biotech Hunter | Biotech Hunter